Story perspectives
AbbVie Commits to Open Data Sharing for Trials
1/4/2026
32 6
1 of 1
Story summary
- AbbVie Inc. announced a commitment to responsible data sharing for its sponsored clinical trials.
- Researchers may request access to anonymized data, trial-level data, and related materials after proposal approval and a Data Sharing Agreement.
- Data will be accessible for 12 months, with potential extensions.
- Details are available at AbbVie's dedicated link for requests, while the sequencing data remains accessible in the Gene Expression Omnibus under accession number GSE305818.
